In This Section

Global Scholar-in-Training Awards Recipients

The AACR is proud to offer Global Scholar-in-Training Awards (GSITA) to support the participation of meritorious early-career scientists from countries building cancer research capacities who wish to participate in the AACR Annual Meeting 2022. The GSITA program, now in its fourth year, will bring fifteen promising scientists from nine countries—Jordan, Nigeria, Peru, India, Colombia, China, Brazil, Serbia, and Argentina—to New Orleans in April. The names and affiliations of the 2022 GSITA recipients, along with the abstract numbers and titles of their abstracts, are listed below.

Hassan Abushukair

Hassan Abushukair

Jordan University of Science and Technology

Irbid, Jordan

Abstract 2727: Overexpression of protocadherin related 15 (PCDH15) gene predicts better prognosis in low-grade glioma patients 

Mary Adetutu Adewunmi

Mary Adetutu Adewunmi

National Centre for Technology Management (NACETEM)

Lagos, Nigeria

Abstract 6391: Scalable Colorectal Cancer (CRC) diagnosis Model with arterial and unenhanced phases of KRAS mutational status using Apache Spark

AJAYI BABAJIDE OLUWASEUN, PhD

AJAYI BABAJIDE OLUWASEUN, PhD

Ajayi Crowther University
Oyo, Nigeria

Abstract 4218: 6-gingerol upregulated CD8+ T cells function in mice model of colorectal cancer via modulation of programmed cell death protein 1/programmed death-ligand1 and cytotoxic 

Andrea Anampa-Guzmán

Andrea Anampa-Guzmán

Universidad Nacional Mayor de San Marcos, San Fernando Medical school

Lima, Perú

Abstract 3656: Breast cancer care quality in Peru 

Titilope Dokunmu, PhD

Titilope Dokunmu, PhD

Covenant University

Ota, Nigeria

Abstract 5850: p53 gene expression and nitric oxide levels after artemisinin-caffeine treatment in breast, lungs and liver of DMBA-induced tumorigenesis 

Delfin Lovelina Francis, MDS

Delfin Lovelina Francis, MDS

All India Institute for Medical Sciences

New Delhi, India

Abstract 2215: Cancer awareness, tobacco use and cessation among Malayali tribes, Yelagiri Hills, Tamil Nadu, India

H. Michelle Guevara-Nieto

H. Michelle Guevara-Nieto

Instituto Nacional de Cancerologia – Universidad Nacional de Colombia

Bogotá, Colombia

Abstract 1255: Identification of predictive biomarkers for neoadjuvant chemotherapy response in invasive breast cancer Latino patients   

Jie Huang, PhD

Jie Huang, PhD

Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine

Hangzhou, China

Abstract 5002: The prognostic relevance and underlying mechanisms of the novel oxygen sensor ADO in cancers 

Rahul Kumar

Rahul Kumar

All India Institute of Medical Sciences

New Delhi, India  

Abstract 2277: Evaluation of mutation profile of oncogenic signaling pathway in breast cancer among Indian population 

Jude Okoye, PhD

Jude Okoye, PhD

Nnamdi Azikiwe University

Nnewi, Nigeria 

Abstract 1496: Circulating mir21 and mir125b in women living with human immunodeficiency virus: Utility of biomarkers for monitoring cervical carcinogenesis  

Barbara Paranhos Coelho, PhD

Barbara Paranhos Coelho, PhD

University of São Paulo,

São Paulo, Brazil  

Abstract 103:Knockout of cellular prion protein in glioblastoma affects the expression of Wnt signaling genes    

Marijana Pavlovic, PhD

Marijana Pavlovic, PhD

Institute for Oncology and Radiology of Serbia

Belgrade, Serbia

Abstract 3463: Nischarin agonist rilmenidine inhibits pancreatic ductal adenocarcinoma cell migration and invasion  

Pablo Sanchis

Pablo Sanchis

University of Buenos Aires – CONICET

Buenos Aires, Argentina

Abstract 2374: Early metabolic rewiring of prostate cancer cells triggered by bone progenitors defines survival of metastatic prostate cancer. 

Xinfeng Wang

Xinfeng Wang

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College 

Beijing, China 

Abstract 5349: Single-cell analysis sheds light on the resistance mechanisms of a novel pan-HER inhibitor, pyrotinib, in non-small cell lung cancer 

Anjali Yadav, PhD

Anjali Yadav, PhD

Indian Institute of Technology Kanpur

Kanpur, India 

Abstract 1542: MALAT1 ablation dismantles homologous recombination repair machinery and sensitizes castrate-resistant prostate cancer cells to PARP inhibitor